Inventor · disambiguated record
Torsten Hoffmann
Also filed as: HOFFMANN TORSTEN · HOFFMANN TORSTEN D
70 granted patents·24 pending applications·1,237 citations·filing 1998–2023
99Inventor score
Top patents by PatentIndex Score
94 records- 0198US8501930B2Peptide-based in vivo siRNA delivery systemROZEMA DAVID B·Filed 2011·Granted Aug 6, 2013·180 cites·18 claims
- 0296US6297375B14-phenyl-pyridine derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Oct 2, 2001·105 cites·65 claims
- 0395US9796756B2Galactose cluster-pharmacokinetic modulator targeting moiety for siRNAARROWHEAD MADISON INC·Filed 2015·Granted Oct 24, 2017·24 cites·20 claims
- 0495US8802773B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2013·Granted Aug 12, 2014·12 cites·22 claims
- 0595US8426554B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2011·Granted Apr 23, 2013·47 cites·14 claims
- 0695US6593472B2NK-1 receptor active amine oxide prodrugsHOFFMANN LA ROCHE·Filed 2001·Granted Jul 15, 2003·73 cites·17 claims
- 0795US6479483B24-phenyl-pyridine derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Nov 12, 2002·75 cites·34 claims
- 0894US7381537B2Use of inhibitors of glutaminyl cyclases for treatment and prevention of diseasePROBIODRUG AG·Filed 2004·Granted Jun 3, 2008·62 cites·27 claims
- 0994US7109347B2Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agentsPROBIODRUG AG·Filed 2005·Granted Sep 19, 2006·19 cites·5 claims
- 1092US6770637B2Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptorsHOFFMANN LA ROCHE·Filed 2001·Granted Aug 3, 2004·54 cites·19 claims
- 1191US7368576B2Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agentsPROBIODRUG AG·Filed 2006·Granted May 6, 2008·9 cites·10 claims
- 1291US6946480B2Glutaminyl based DPIV inhibitorsDEMUTH HANS-ULRICH·Filed 2002·Granted Sep 20, 2005·34 cites·9 claims
- 1390US6319893B1Raising blood sugar level in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IVPROBIODRUG·Filed 1999·Granted Nov 20, 2001·120 cites·4 claims
- 1489US7462599B2Use of effectors of glutaminyl and glutamate cyclasesPROBIODRUG AG·Filed 2004·Granted Dec 9, 2008·31 cites·14 claims
- 1589US7053055B2Compounds of unstable DP IV-inhibitorsPROSIDION LTD·Filed 2000·Granted May 30, 2006·44 cites·16 claims
- 1689US6407111B1Phenyl substituted pyridine and benzene derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Jun 18, 2002·31 cites·12 claims
- 1786US9011919B2Compositions for targeted delivery of siRNAROZEMA DAVID B·Filed 2012·Granted Apr 21, 2015·7 cites·22 claims
- 1886US6949515B2Effectors of dipeptidyl peptidase IV for topical usePROBIODRUG AG·Filed 2002·Granted Sep 27, 2005·22 cites·19 claims
- 1986US6225316B13-phenyl-pyridine-derivativesHOFFMANN LA ROCHE·Filed 2000·Granted May 1, 2001·25 cites·24 claims
- 2085US9650362B2InhibitorsPROBIODRUG AG·Filed 2015·Granted May 16, 2017·5 cites·17 claims
- 2185US7084120B2Prodrugs of DP IV-inhibitorsPROBIODRUG AG·Filed 2000·Granted Aug 1, 2006·25 cites·7 claims
- 2285US6747026B2NK-1 receptor active amine oxide prodrugsHOFFMANN LA ROCHE·Filed 2003·Granted Jun 8, 2004·17 cites·7 claims
- 2384US9249179B2Galactose cluster-pharmacokinetic modulator targeting moiety for siRNAHADWIGER PHILIPP·Filed 2011·Granted Feb 2, 2016·10 cites·5 claims
- 2484US7939533B2Dual NK1/NK3 receptor antagonistsHOFFMANN LA ROCHE·Filed 2009·Granted May 10, 2011·5 cites·8 claims
- 2584US6806370B2NK-1 receptor active amine oxide prodrugsHOFFMANN LA ROCHE·Filed 2003·Granted Oct 19, 2004·15 cites·13 claims
- 2683US9301990B2Small molecule conjugates for intracellular delivery of biologically active compoundsHOFFMANN LA ROCHE·Filed 2013·Granted Apr 5, 2016·2 cites·6 claims
- 2783US9107957B2Peptide-based in vivo siRNA delivery systemARROWHEAD MADISON INC·Filed 2013·Granted Aug 18, 2015·5 cites·14 claims
- 2883US7211579B2NK-1 receptor antagonistsHOFFMANN LA ROCHE·Filed 2006·Granted May 1, 2007·11 cites·5 claims
- 2983US6596773B2Phenyl substituted pyridine and benzene derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Jul 22, 2003·16 cites·7 claims
- 3081US6849624B2Aromatic and heteroaromatic substituted amidesHOFFMANN LA ROCHE·Filed 2002·Granted Feb 1, 2005·17 cites·9 claims
- 3180US9968647B2Small molecule conjugates for intracellular delivery of biologically active compoundsHOFFMANN LA ROCHE·Filed 2016·Granted May 15, 2018·1 cites·3 claims
- 3280US7893062B2Pyrrolidine derivatives as dual NK1/NK3 receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Feb 22, 2011·4 cites·15 claims
- 3379US8809010B2Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclasesHOFFMANN TORSTEN·Filed 2009·Granted Aug 19, 2014·3 cites·13 claims
- 3479US8227498B2Inhibitors of glutaminyl cyclaseBUCHHOLZ MIRKO·Filed 2008·Granted Jul 24, 2012·5 cites·24 claims
- 3579US6576762B2Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptorsHOFFMANN LA ROCHE·Filed 2001·Granted Jun 10, 2003·10 cites·3 claims
- 3679US6274588B14-phenyl-pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Aug 14, 2001·13 cites·11 claims
- 3778US9198947B2Small molecule conjugates for intracellular delivery of nucleic acidsHOFFMANN LA ROCHE·Filed 2013·Granted Dec 1, 2015·1 cites·5 claims
- 3878US8889709B2Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditionsDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 18, 2014·4 cites·37 claims
- 3978US8486940B2InhibitorsHEISER ULRICH·Filed 2010·Granted Jul 16, 2013·4 cites·33 claims
- 4077US7816325B2Secondary binding site of dipeptidyl peptidase IV (DP IV)OSI PHARM INC·Filed 2006·Granted Oct 19, 2010·1 cites·18 claims
- 4177US6262089B1D-proline derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Jul 17, 2001·7 cites·10 claims
- 4276US12384772B2InhibitorsVIVORYON THERAPEUTICS N V·Filed 2022·Granted Aug 12, 2025·0 cites·7 claims
- 4376US7368421B2Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosisPROBIODRUG AG·Filed 2002·Granted May 6, 2008·4 cites·13 claims
- 4476US6756380B15-phenyl-pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Jun 29, 2004·9 cites·15 claims
- 4574US9173885B2InhibitorsPROBIODRUG AG·Filed 2013·Granted Nov 3, 2015·2 cites·32 claims
- 4674US7166579B2Prodrugs of DP IV-inhibitorsPROSIDION LTD·Filed 2003·Granted Jan 23, 2007·7 cites·12 claims
- 4774US6103910AD-proline derivativesHOFFMANN LA ROCHE·Filed 1998·Granted Aug 15, 2000·25 cites·102 claims
- 4873US6512001B1D-proline derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Jan 28, 2003·4 cites·11 claims
- 4972US6482829B2Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptorHOFFMANN LA ROCHE·Filed 2001·Granted Nov 19, 2002·6 cites·211 claims
- 5070US7060719B2Glutaminyl based DPIV inhibitorsPROSIDION LTD·Filed 2004·Granted Jun 13, 2006·3 cites·18 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Torsten Hoffmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →